Obermeyer Wealth Partners grew its position in shares of DuPont de Nemours, Inc. (NYSE:DD – Free Report) by 54.2% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 13,551 shares of the basic materials company’s stock after purchasing an additional 4,763 shares during the quarter. Obermeyer Wealth Partners’ holdings in DuPont de Nemours were worth $1,760,000 as of its most recent SEC filing.
Several other hedge funds have also recently added to or reduced their stakes in the company. Physician Wealth Advisors Inc. lifted its position in shares of DuPont de Nemours by 223.1% in the 3rd quarter. Physician Wealth Advisors Inc. now owns 210 shares of the basic materials company’s stock worth $27,000 after purchasing an additional 145 shares during the period. Elevation Wealth Partners LLC boosted its stake in shares of DuPont de Nemours by 168.5% in the 2nd quarter. Elevation Wealth Partners LLC now owns 239 shares of the basic materials company’s stock valued at $32,000 after purchasing an additional 150 shares during the last quarter. Bangor Savings Bank acquired a new stake in shares of DuPont de Nemours during the third quarter worth $36,000. Grove Bank & Trust acquired a new stake in shares of DuPont de Nemours during the third quarter worth $40,000. Finally, Coastline Trust Co bought a new position in DuPont de Nemours during the third quarter worth $44,000. Institutional investors own 73.96% of the company’s stock.
DuPont de Nemours Stock Up 0.9%
Shares of NYSE:DD opened at $134.11 on Thursday. DuPont de Nemours, Inc. has a 52-week low of $99.20 and a 52-week high of $157.98. The business’s 50 day simple moving average is $132.62 and its two-hundred day simple moving average is $138.13. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.82 and a current ratio of 2.43. The firm has a market cap of $18.11 billion, a P/E ratio of 298.08, a PEG ratio of 1.23 and a beta of 1.05.
DuPont de Nemours (NYSE:DD – Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The basic materials company reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.76 by $0.12. The business had revenue of $1.82 billion during the quarter, compared to the consensus estimate of $1.81 billion. DuPont de Nemours had a net margin of 0.67% and a return on equity of 6.92%. DuPont de Nemours’s revenue was up 4.0% compared to the same quarter last year. During the same quarter last year, the firm posted $1.12 EPS. DuPont de Nemours has set its Q3 2026 guidance at 1.800-1.900 EPS. As a group, research analysts forecast that DuPont de Nemours, Inc. will post 7.25 EPS for the current fiscal year.
DuPont de Nemours Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Monday, November 30th will be issued a dividend of $0.60 per share. The ex-dividend date is Monday, November 30th. This represents a $2.40 annualized dividend and a yield of 1.8%. DuPont de Nemours’s dividend payout ratio is 533.33%.
Wall Street Analysts Forecast Growth
A number of brokerages recently weighed in on DD. Weiss Ratings reissued a “sell (d+)” rating on shares of DuPont de Nemours in a research note on Monday, August 3rd. Royal Bank Of Canada decreased their price target on DuPont de Nemours from $176.00 to $160.00 and set an “outperform” rating for the company in a report on Thursday, October 15th. The Goldman Sachs Group decreased their price target on DuPont de Nemours from $159.00 to $153.00 and set a “neutral” rating for the company in a report on Wednesday, September 30th. Citigroup lowered their price objective on DuPont de Nemours from $170.00 to $162.00 and set a “buy” rating for the company in a research report on Wednesday, October 7th. Finally, Barclays began coverage on DuPont de Nemours in a research note on Tuesday, October 13th. They issued an “overweight” rating and a $156.00 price objective on the stock. One equities research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, DuPont de Nemours has an average rating of “Moderate Buy” and an average price target of $162.00.
Get Our Latest Report on DuPont de Nemours
DuPont de Nemours Company Profile
DuPont de Nemours, Inc is a diversified science and technology company that develops engineered materials and specialty products for industrial and consumer markets. Its offerings are used in applications including electronics, semiconductor manufacturing, water purification, transportation, construction, healthcare, and worker and consumer protection.
The company’s product portfolio has historically included high-performance films, resins, adhesives, engineered polymers, specialty fibers, protective materials, water-treatment membranes, and filtration technologies.
Featured Stories
- Five stocks we like better than DuPont de Nemours
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
Want to see what other hedge funds are holding DD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DuPont de Nemours, Inc. (NYSE:DD – Free Report).
Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.
